Financial insights of VNRX

MyFinsight

For the year ending 2025-12-31, VNRX made $1,727,384 in revenue. -$24,184,031 in net income. Net profit margin of -1400.04%.

Income Statement	2025-12-31	2024-12-31
Total revenues	1,727,384	1,233,511
Research and development	10,081,299	14,406,486
General and administrative	9,463,581	8,487,562
Sales and marketing	3,921,075	5,364,433
Total operating expenses	23,465,955	28,258,481
Operating loss	-21,738,571	-27,024,970
Grant income	516,515	103,368
Gain /( loss) on disposal of fixed assets	1,829	-34,731
Interest income	600	9,947
Interest expense	532,192	340,362
Amortization of debt discount	1,957,147	-
Gain on change in fair value of warrant liability	76,908	-
Gain on change in fair value of derivative liability	128,729	28,763
Total other income (expenses)	-1,764,758	-233,015
Net loss	-23,503,329	-
Net loss attributable to non-controlling interest	146,302	-
Net loss attributable to volitionrx limited stockholders	-23,357,027	-27,257,985
Net loss attributable to non-controlling interest	-	-290,149
Foreign currency translation adjustments	-680,702	-
Net loss attributable to volitionrx limited stockholders	-	-26,967,836
Net comprehensive loss	-24,184,031	-

Diluted EPS	-	-0.31
Diluted Average Shares	106,832,140	86,531,172